Article Versions Notes

Koenig O, Walker T, Perle N, Zech A, Neumann B, Schlensak C, Wendel H-P, Nolte A. New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases. Pharmaceuticals. 2013; 6(7):881-914. https://doi.org/10.3390/ph6070881

Koenig, Olivia, Tobias Walker, Nadja Perle, Almuth Zech, Bernd Neumann, Christian Schlensak, Hans-Peter Wendel, and Andrea Nolte. 2013. "New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases" Pharmaceuticals 6, no. 7: 881-914. https://doi.org/10.3390/ph6070881

Koenig, O., Walker, T., Perle, N., Zech, A., Neumann, B., Schlensak, C., Wendel, H.-P., & Nolte, A. (2013). New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases. Pharmaceuticals, 6(7), 881-914. https://doi.org/10.3390/ph6070881